Have spoken to SB as well and it's all been covered here …
The Friday announcement will cover it all I expect and hopefully most will be satisfied. Everything is on track - incl. reserves announcement expected in April, but as mentioned by others well testing costs during the quarter have upped outgoings relatively high for the quarter hence the CR need.
Whatever blip happens for the CR, hopefully it'll be short-lived this time as the market focuses on what's ahead. Yes the OA extension aim is a major tick. Is subject to ASX waivers but RLE has very good cause for it …
SB is working very hard I reckon to line the ducks up so I'm very happy to cut him some slack. Not pleased by the small dilution and the interruption to momentum, but the extension to the OA's if it comes off will be a very adequate off-set, both for me personally and for the benefit of the company.
Kip
RLE Price at posting:
13.5¢ Sentiment: Buy Disclosure: Held